Metformin Vitabalans

Metformin hydrochloride, the active ingredient in Metformin Vitabalans, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus and related metabolic conditions. GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans belongs to the biguanide class and is employed in the management of disorders involving impaired glucose regulation.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. Prediabetes: reduces the risk of progression to overt diabetes. Polycystic ovary syndrome (PCOS): helps improve insulin resistance and may restore ovulatory function.

Metformin is generally well tolerated, but a range of adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Loss of appetite. - Mild weight loss. - Vitamin B12 deficiency with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity: elevated liver enzymes. - Hypersensitivity reactions: rash, itching, or swelling. - Persistent gastrointestinal bleeding.

Metformin should be used with awareness of specific safety considerations. - Renal function: assess creatinine clearance before initiating and periodically thereafter. - Hepatic impairment: avoid in patients with significant liver disease. - Cardiovascular status: use cautiously in patients with unstable heart failure. - Pregnancy and lactation: discuss risks and benefits with a healthcare professional. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (especially thiazides): can affect renal function and electrolyte balance. - ACE inhibitors or ARBs: monitor renal function when combined. - Alcohol: excessive intake may increase lactic acidosis risk. - Antiretroviral agents (e.g., protease inhibitors): may elevate metformin levels.